Post-marketing Surveillance for Combined Oral Contraceptive Containing Desogestrel (Marvelon®) in Chinese Rural Areas
Tang, H.; Li, Y.; Wu, Y.; Zhou, J.; Ba, L.; Gu, X.; Wang, W.; Yao, H.; Ren, N.; Chen, J.; Xu, L.
Journal of Reproduction and Contraception 19(4): 193-200
2008
ISSN/ISBN: 1001-7844 Document Number: 203597
Document emailed within 1 workday
Related Documents
Peters, K.; Gordon, N.; Ricciotti, N.; Hsieh, J.; Howard, B.; Weiss, H. 2016: Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study Clinical and Experimental Obstetrics and Gynecology 43(3): 334-340Kriplani, A.; Periyasamy, A.J.; Agarwal, N.; Kulshrestha, V.; Kumar, A.; Ammini, A.C. 2010: Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome Contraception 82(2): 139-146
Rioufol, C.; Vial, T.; Pulce, C.; Descotes, J. 2002: Correspondents in post- marketing surveillance, drug dependence surveillance, and toxicovigilance: definition and roles Therapie 57(2): 201-204
Yang, Z.-J.; Ye, W.-S.; Cui, G.-H.; Guo, Y.; Xue, S.-P. 2004: Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men Contraception 70(3): 203-211
Wang, C.; Li, Y.; Bai, J.; Qian, W.; Zhou, J.; Sun, Z.; Ba, L.; Wei, W.; Li, H.; Sun, T. 2011: General and central obesity, combined oral contraceptive use and hypertension in Chinese women American Journal of Hypertension 24(12): 1324-1330
Singh, R.P. 1980: The pattern of supply, distribution and use of oral contraceptive pill in rural areas in Uttar Pradesh Popcen News Letter. Population Centre 5(6): 7-10
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Leufkens, H.G.; Heerdink, E.R. 1996: Post-marketing surveillance Nederlands Tijdschrift Voor Geneeskunde 140(22): 1201-2; Author Reply 1202
Offerhaus, L. 1996: Post-marketing surveillance Nederlands Tijdschrift Voor Geneeskunde 140(22): 1201; Author Reply 1202
Chen, C.; Li, Y.; Chen, F.; Pan, H.; Shen, H.; Sun, Z.; Wu, Y.; Zhou, J.; Ba, L.; Zhao, J. 2010: Estrogen receptor beta genetic variants and combined oral contraceptive use as relates to the risk of hypertension in Chinese women Archives of Medical Research 41(8): 599-605
Klipping, C.; Marr, J. 2005: Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism Contraception (Stoneham) 71(6): 409-416
Fjaerestad, I. 1986: Marvelon--when adverse effects become marketing arguments Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(23): 1865-1866
Wakisaka, K.; Tani, S.; Ishibashi, K.; Nukui, K.; Nagao, M. 2015: Results of a post-marketing surveillance of meropenem for febrile neutropenia Japanese Journal of Antibiotics 68(4): 205-224
Albengres, E.; Gauthier, F.; Tillement, J.P. 1990: Current French system of post-marketing drug surveillance International Journal of Clinical Pharmacology Therapy and Toxicology 28(7): 312-314
Stuart, G.S.; Moses, A.; Corbett, A.; Phiri, G.; Kumwenda, W.; Mkandawire, N.; Chintedze, J.; Malunga, G.; Hosseinipour, M.; Cohen, M.S.; Stanczyk, F.Z.; Kashuba, A.D.M. 2011: Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi Journal of Acquired Immune Deficiency Syndromes 58(2): E40-E43
Weisberg, E.; Merki-Feld, G.S.; McGeechan, K.; Fraser, I.S. 2015: Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen Contraception 91(2): 121-126
Jones, C.W. 1996: A post-marketing surveillance study of Voltarol 75 mg SR in the primary care setting British Journal of Clinical Practice 50(7): 390-395
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292